IPD - biotech
Brisbane, Australia - ImpediMed Limited (ASX:IPD) (“ImpediMed” or the “Company”) is pleased to announce that it has received binding commitments for a significantly
oversubscribed placement of shares with domestic and international institutional investors and sophisticated investors (the “Placement”). The Placement, which was strongly supported by both existing and new shareholders, is for approximately 45.3 million shares at A$0.195 per share, raising approximately A$8.8 million.
Morgans has a target range of 0.32-0.45 , Wilson HTM - 0.45 and Cannacord - 0.60
- Forums
- ASX - Day Trading
- daytrading march 28 pre-market
daytrading march 28 pre-market, page-22
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)